Filing Details
- Accession Number:
- 0001140361-17-034162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-01 17:26:31
- Reporting Period:
- 2017-08-31
- Accepted Time:
- 2017-09-01 16:26:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1017491 | Apricus Biosciences Inc. | APRI | Pharmaceutical Preparations (2834) | 870449967 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1361754 | J Alexander Denner | C/O Sarissa Capital Management Lp 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No | |
| 1575277 | Sarissa Capital Domestic Fund Lp | C/O Sarissa Capital Management Lp 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No | |
| 1577524 | Sarissa Capital Management Lp | 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No | |
| 1577530 | Sarissa Capital Offshore Master Fund Lp | C/O Sarissa Capital Management 660 Steamboat Road 3Rd Floor Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-31 | 6,104 | $1.63 | 1,447,906 | No | 4 | P | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants to purchase Common Stock | Acquisiton | 2017-08-31 | 2,835 | $0.00 | 2,835 | $8.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 672,453 | 2016-09-04 | 2023-03-03 | No | 4 | P | Indirect |
Footnotes
- On August 31, 2017, in connection with a private transaction with Sarissa Capital Master Offshore Fund LP, a Cayman Island exempted limited partnership ("Sarissa Offshore"), and Sarissa Capital Domestic Fund LP, a Delaware limited partnership ("Sarissa Domestic"), Dr. Alexander Denner increased his pecuniary interest in shares of common stock and warrants to purchase common stock of Apricus Biosciences, Inc. through his direct interest in Sarissa Domestic and his indirect interest in Sarissa Offshore.
- All shares and warrants reported herein as of August 31, 2017 are beneficially owned by Sarissa Offshore. Sarissa Capital Management GP LLC, a Delaware limited liability company ("Sarissa Capital GP"), is the general partner of Sarissa Capital Management LP, a Delaware limited partnership ("Sarissa Capital"), the investment advisor to Sarissa Offshore. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member of Sarissa Capital GP. By virtue of the foregoing, Sarissa Capital and Dr. Denner may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the shares and warrants that Sarissa Offshore directly beneficially owns. Sarissa Capital and Dr. Denner disclaim beneficial ownership of these shares and warrants except to the extent of any pecuniary interest therein.
- The shares of common stock and warrant reported herein were acquired at the per share price referred to above.
Billionaire Hedge Funds
